Aspira Pathlab & Diagnostics Ltd
About
[
edit
]
Aspira Pathlab & Diagnostics is engaged in the business of running, owning, managing and administering Diagnostics Centers. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai.
[
add key points
]
- Market Cap ₹ 26.5 Cr.
- Current Price ₹ 28.5
- High / Low ₹ 38.3 / 20.0
- Stock P/E
- Book Value ₹ 4.84
- Dividend Yield 0.00 %
- ROCE -25.1 %
- ROE -82.4 %
- Face Value ₹ 10.0
Pros
- No pros found. Suggest something.
Cons
- Stock is trading at 5.89 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of -132.39% for last 3 years.
- Promoter holding has decreased over last 3 years: -12.36%
Peer comparison
Sector: Healthcare Industry: Healthcare
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1.47 | 1.48 | 2.00 | 2.08 | 2.08 | 1.90 | 2.33 | 2.22 | 1.97 | 1.52 | 5.38 | 4.19 | |
2.49 | 2.33 | 2.82 | 2.91 | 2.83 | 2.37 | 2.61 | 2.60 | 2.69 | 1.62 | 3.52 | 3.41 | |
Operating Profit | -1.02 | -0.85 | -0.82 | -0.83 | -0.75 | -0.47 | -0.28 | -0.38 | -0.72 | -0.10 | 1.86 | 0.78 |
OPM % | -69.39% | -57.43% | -41.00% | -39.90% | -36.06% | -24.74% | -12.02% | -17.12% | -36.55% | -6.58% | 34.57% | 18.62% |
Other Income | 0.07 | 0.05 | 0.06 | 0.07 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 |
Interest | 0.29 | 0.28 | 0.26 | 0.16 | 0.26 | 0.25 | 0.24 | 0.28 | 0.25 | 0.24 | 0.25 | 0.22 |
Depreciation | 0.13 | 0.29 | 0.31 | 0.31 | 0.32 | 0.40 | 0.41 | 0.43 | 0.42 | 0.36 | 0.35 | 0.37 |
Profit before tax | -1.37 | -1.37 | -1.33 | -1.23 | -1.25 | -1.05 | -0.86 | -1.02 | -1.32 | -0.63 | 1.33 | 0.25 |
Tax % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
Net Profit | -1.37 | -1.38 | -1.33 | -1.23 | -1.24 | -1.05 | -0.86 | -1.02 | -1.32 | -0.63 | 1.33 | 0.26 |
EPS in Rs | -2.64 | -2.66 | -1.62 | -1.50 | -1.51 | -1.28 | -1.05 | -1.10 | -1.42 | -0.68 | 1.43 | 0.28 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Figures in Rs. Crores
Mar 2010 | Mar 2011 | Mar 2012 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|
-0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.76 | 4.36 | 7.64 | 8.42 | 13.06 | |
0.02 | 0.02 | 0.02 | 0.14 | 0.23 | 3.34 | 8.24 | 10.88 | 10.25 | 11.24 | |
Operating Profit | -0.02 | -0.02 | -0.02 | -0.14 | -0.23 | -2.58 | -3.88 | -3.24 | -1.83 | 1.82 |
OPM % | -339.47% | -88.99% | -42.41% | -21.73% | 13.94% | |||||
Other Income | 0.34 | 0.15 | 0.02 | 0.21 | 0.32 | 0.31 | 0.22 | 0.25 | 0.29 | 0.27 |
Interest | 0.06 | 0.05 | -0.00 | -0.00 | 0.05 | 0.26 | 0.80 | 0.96 | 1.01 | 0.96 |
Depreciation | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.20 | 1.12 | 1.23 | 1.66 | 1.50 |
Profit before tax | 0.26 | 0.08 | -0.00 | 0.07 | 0.04 | -2.73 | -5.58 | -5.18 | -4.21 | -0.37 |
Tax % | 23.08% | 37.50% | 57.14% | 25.00% | -0.00% | -0.00% | -0.00% | -0.71% | ||
Net Profit | 0.20 | 0.05 | -0.00 | 0.02 | 0.03 | -2.72 | -5.58 | -5.18 | -4.24 | -0.36 |
EPS in Rs | 5.00 | 1.25 | -0.00 | 0.09 | 0.13 | -5.24 | -10.75 | -6.32 | -4.56 | -0.39 |
Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 123% |
TTM: | 53% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -24% |
TTM: | 91% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 26% |
1 Year: | -26% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | -90% |
3 Years: | -132% |
Last Year: | -82% |
Balance Sheet
Figures in Rs. Crores
Mar 2010 | Mar 2011 | Mar 2012 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
0.40 | 0.40 | 0.40 | 2.25 | 2.25 | 5.19 | 5.19 | 13.73 | 14.91 | 9.29 | |
Reserves | 0.13 | 0.19 | 0.19 | 1.36 | 1.39 | 0.72 | -4.86 | -7.93 | -10.42 | -4.79 |
Borrowings | 1.33 | 0.06 | -0.00 | -0.00 | 2.62 | 7.29 | 11.36 | 6.98 | 8.19 | 8.51 |
0.20 | 0.01 | 0.03 | 0.21 | 0.03 | 1.66 | 0.84 | 7.56 | 7.28 | 2.35 | |
Total Liabilities | 2.06 | 0.66 | 0.62 | 3.82 | 6.29 | 14.86 | 12.53 | 14.80 | 14.34 | 15.36 |
-0.00 | -0.00 | -0.00 | -0.00 | 0.04 | 7.79 | 7.91 | 8.90 | 8.70 | 8.17 | |
CWIP | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.25 | -0.00 | -0.00 | -0.00 | -0.00 |
Investments | 0.37 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
1.69 | 0.66 | 0.62 | 3.82 | 6.25 | 6.82 | 4.62 | 5.90 | 5.64 | 7.19 | |
Total Assets | 2.06 | 0.66 | 0.62 | 3.82 | 6.29 | 14.86 | 12.53 | 14.80 | 14.34 | 15.36 |
Cash Flows
Figures in Rs. Crores
Mar 2010 | Mar 2011 | Mar 2012 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|
-0.02 | -0.04 | -0.02 | -0.37 | -1.29 | -4.81 | -3.39 | -1.87 | ||
-1.24 | 1.35 | 0.08 | -0.02 | -10.14 | -0.77 | -1.97 | 0.24 | ||
0.61 | -1.33 | -0.06 | 2.64 | 8.91 | 6.52 | 3.35 | 1.27 | ||
Net Cash Flow | -0.65 | -0.02 | -0.00 | 2.25 | -2.52 | 0.94 | -2.00 | -0.35 |
Ratios
Figures in Rs. Crores
Mar 2010 | Mar 2011 | Mar 2012 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|
ROCE % | 10.36% | -0.00% | 1.82% | -25.39% | -38.41% | -34.49% | -25.14% | ||
Debtor Days | 43.22 | 29.30 | 38.22 | 26.01 | |||||
Inventory Turnover | -0.00 | 4.33 | 7.02 | 8.46 | 8.25 |
Documents
Add documentRecent announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 17 Feb
- Appointment of Company Secretary and Compliance Officer 13 Feb
- Appointment Of Chief Financial Officer And Key Managerial Personnel (KMP) Of The Company Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 13 Feb
- Unaudited Financial Results For The Quarter Ended December 31, 2020. 13 Feb
- Outcome Of Meeting Of The Board Of Directors Held On February 13, 2021, Pursuant To Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 13 Feb
View all